
CKM Syndrome Reveals 90% of Americans Are on a Heart–Kidney–Metabolic Risk Path
CKM syndrome, formalized by the AHA in 2023, is a four-stage framework showing how overweight, high blood pressure, high blood sugar, and reduced kidney function connect cardiovascular, kidney, and metabolic diseases; about 90% of U.S. adults fall somewhere on the spectrum, from risk (Stage 0) to overt disease, with prevention centered on lifestyle changes and newer medications like GLP-1s, SGLT2 inhibitors, and nsMRAs that benefit multiple organs.













